Kyverna Therapeutics
northpond ventures
bio & pharma
2. 11-50
Kyverna is a cell therapy company engineering and developing a new class of curative living medicines for inflammatory and autoimmune diseases. Using its SmarTcell™ approach which includes synReg-T cell and synNotch CAR-T technology platforms, Kyverna reprograms T cells to target and selectively suppress or eliminate autoreactive immune cells. The company’s goal is to develop therapies that are selective, potent and durable to tame autoimmunity.
synNotch is a trademark of Gilead/Kite.
kyvernatx.comEmeryville, CA, USA
Founded in 2018
Inaccurate data? Flag it here.Open jobs at Kyverna Therapeutics